S

Scilex Holding Co
NASDAQ:SCLX

Watchlist Manager
Scilex Holding Co
NASDAQ:SCLX
Watchlist
Price: 11.34 USD -1.05% Market Closed
Market Cap: 86.1m USD

Relative Value

There is not enough data to reliably calculate the relative value of SCLX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SCLX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
6.1
Median 5Y
2.3
Industry
2.7
Forward
1.5
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2.4
Industry
21.4
Forward
-0.5
vs History
vs Industry
Median 3Y
-14.8
Median 5Y
-22.8
Industry
16.8
vs History
vs Industry
Median 3Y
48.5
Median 5Y
19.1
Industry
23.1
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.5
Industry
2.3
vs History
vs Industry
Median 3Y
8.7
Median 5Y
4.9
Industry
2.9
Forward
3.6
vs History
vs Industry
Median 3Y
13.2
Median 5Y
7.3
Industry
5.5
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-5.4
Industry
13.3
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-5.2
Industry
16.5
Forward
-2.8
vs History
vs Industry
Median 3Y
-20.6
Median 5Y
-29.9
Industry
16
vs History
vs Industry
Median 3Y
-20.3
Median 5Y
-29.5
Industry
18.9
vs History
vs Industry
Median 3Y
7.6
Median 5Y
4.1
Industry
2

Multiples Across Competitors

SCLX Competitors Multiples
Scilex Holding Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Scilex Holding Co
NASDAQ:SCLX
86.1m USD 1.8 -0.5 -2 -2
US
Eli Lilly and Co
NYSE:LLY
982.2B USD 16.5 53.3 35.8 38.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
526.1B USD 5.7 20.9 17.1 22.2
CH
Roche Holding AG
SIX:ROG
277.8B CHF 4.5 29.5 12.5 14.6
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP 5 31 108.8 159.2
CH
Novartis AG
SIX:NOVN
221.8B CHF 4.9 19.2 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
270.7B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.5 16.6 11.6 13.4
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
145.8B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
US
S
Scilex Holding Co
NASDAQ:SCLX
Average P/E: 25
Negative Multiple: -0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.3
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
37%
0.8
CH
Novartis AG
SIX:NOVN
19.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
16.6
3%
5.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Scilex Holding Co
NASDAQ:SCLX
Average EV/EBITDA: 440
Negative Multiple: -2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.8
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.1
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
12.1
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.6
1%
11.6
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
S
Scilex Holding Co
NASDAQ:SCLX
Average EV/EBIT: 1 883.7
Negative Multiple: -2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.4
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.2
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.6
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
CH
Novartis AG
SIX:NOVN
15.7
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5